Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vanesa Sekeruš"'
Autor:
Daliborka Bursac, Bojan Zarić, Tomi Kovačević, Vladimir Stojšić, Anastasios Vagionas, Ioannis Boukovinas, Kosmas Tsakiridis, Christoforos Kosmidis, Konstantinos Sapalidis, Konstantinos Romanidis, Nikolaos Courcoutsakis, Dimitris Matthaios, Paul Zarogoulidis, Chrysanthi Sardeli, Vanesa Sekerus
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 716-724 (2021)
Traditionally, tissue availability from rebiopsy is a prerequisite for adequate sequencing of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in therapy for advanced-stage lung cancer. Tissue biopsy truly is the gold standard
Externí odkaz:
https://doaj.org/article/f345fecc4a12422d8fd4ac6c820843ba
Autor:
Bojan Stanimirov, Nebojša Pavlović, Maja Đanić, Vanesa Sekeruš, Jasmina Katanić, Momir Mikov, Karmen Stankov
Publikováno v:
Macedonian Pharmaceutical Bulletin. 68:363-364
Autor:
Konstantinos Sapalidis, Dimitris Matthaios, Chrysanthi Sardeli, Nikolaos Courcoutsakis, Paul Zarogoulidis, Tomi Kovacevic, Konstantinos Romanidis, Christoforos Kosmidis, Bojan Zaric, Daliborka Bursac, Anastasios Vagionas, Vanesa Sekeruš, Ioannis Boukovinas, Vladimir Stojsic, Kosmas Tsakiridis
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 2, Pp 716-724 (2021)
Case Reports in Oncology, Vol 14, Iss 2, Pp 716-724 (2021)
Traditionally, tissue availability from rebiopsy is a prerequisite for adequate sequencing of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in therapy for advanced-stage lung cancer. Tissue biopsy truly is the gold standard
Autor:
Vasiljević Tijana, Ivanić Milena, Tegeltija Dragana, Vanesa Sekeruš, Lovrenski Aleksandra, Kuhajda Ivan, Miroslav Ilic, Maksimović Siniša, Bijelović Milorad
Publikováno v:
Respiratio. 9:30-35
Autor:
Iva Barjaktarović, Katarina Baculov, Jelena Stojcevic-Maletic, Vanesa Sekeruš, Borko Milanović, Nataša Vučinić
Publikováno v:
Medical review. 72:148-153
Introduction. The alpha-1 antitrypsin deficiency is the best described genetic cause of chronic obstructive pulmonary disease. The study of the alpha-1 antitrypsin deficiency, as the most important genetic risk factor for chronic obstructive pulmonar
Autor:
Charilaos Koulouris, Qiang Li, Isaac Kesisoglou, Aikaterini Amaniti, Haidong Huang, Ioannis Passos, Yunye Ning, Athanasios Katsaounis, Bojan Zaric, Chong Bai, Dimitrios Giannakidis, Jelica Eremić Đođić, Marijela Potic, Konstantinos Sapalidis, Nikolaos V. Michalopoulos, Fotis Konstantinou, Jelena Perin, Stylianos Mantalovas, Christoforos Kosmidis, Hui Shi, Chrysanthi Sardeli, Stella Laskou, Efstathios T Pavlidis, Zoran Potic, Branislav Perin, Vanesa Sekeruš
Publikováno v:
Journal of Cancer
Assessing the lung cancer treatment costs is necessary in order to estimate the budget impact of new interventions and therapeutic innovations. However, there are few studies regarding the use of resources and costs associated with treatment of lung
Autor:
Nikolina Kastratovic, Natasa Zdravkovic, Ivan Cekerevac, Vanesa Sekerus, Carl Randall Harrell, Violeta Mladenovic, Aleksandar Djukic, Ana Volarevic, Marija Brankovic, Tijana Gmizic, Marija Zdravkovic, Jelica Bjekic-Macut, Nebojsa Zdravkovic, Valentin Djonov, Vladislav Volarevic
Publikováno v:
Diseases, Vol 12, Iss 7, p 144 (2024)
Smoke derived from combustible cigarettes (CCs) contains numerous harmful chemicals that can impair the viability, proliferation, and activation of immune cells, affecting the progression of chronic inflammatory diseases. In order to avoid the detrim
Externí odkaz:
https://doaj.org/article/137494448fa549f99230443806c06817